For too long, the audience targeting industry has forced a choice: the precision of deterministic data, or the reach of probabilistic modeling.
HealthVerity and Symphony Health end that tradeoff. As the nation’s most robust ecosystem that’s built for breakthroughs across every audience decision, our privacy certified, HIPAA-compliant data lets you blend the surgical accuracy of deterministic matching with the scale of probabilistic reach in a single audience strategy. Both approaches run on the same comprehensive real-world data backbone.
We know that no two campaigns are the same. That’s why we’ve built a two-pronged engine to match your goals, powered by the most comprehensive healthcare data in the country.
The result? Better data in, better audiences out.
Your audiences are built on confirmed clinical evidence like diagnoses, procedures, prescriptions and resolved to anonymous patient IDs.
Best For: Specialty pharmacy and campaigns where accuracy is non-negotiable (i.e. rare disease)
Using industry-leading machine learning and propensity scoring, we model likelihood to find the patients and caregivers your brand needs, even where the signal is faint.
Best For: Broad commercial launches, competitive shifts and situations where you need to move the needle at scale.
Both approaches are built on the nation’s largest real-world data ecosystem. Other audience providers rely on open claims data that covers less than 40% of market activity, then apply predictive modeling that offers little insight into how segments are actually defined. We do the opposite: verified clinical signal first, modeling second, transparency throughout.
De-identified patients
Active HCPs captured across every specialty
Longitudinal healthcare transactions
Pharmacy network coverage in the market
From rare disease cohorts that outperform the market by 3x to chronic liver disease campaigns scoring 17% higher than the next-best competitor, our audiences deliver measurable results.
HealthVerity Audiences delivered the highest audience quality score in a DTC campaign for Chronic Liver Disease and Chronic Immune Thrombocytopenia therapies. Performance was validated by a top-3 health DSP against seven competing providers.
When measuring performance across two rare disease brands with a low prevalence of 0.0204% and 0.0077%, HealthVerity delivered an AQ Index over 550% higher than comparable, legacy third-party audience partners.
Activate across any digital channel in your existing stack. Our audiences are built to deploy wherever your media runs, through the DSPs and activation platforms you already work with.
HealthVerity is a premier provider of HIPAA-compliant, clinical-based patient and HCP targeting segments. Rather than locking you into a single proprietary DSP, HealthVerity Audiences are channel-agnostic and deploy directly into your choice of leading healthcare programmatic advertising platforms and health-specific DSPs.
HealthVerity provides industry-leading, privacy-protected patient targeting segments built directly on the nation's largest healthcare claims database. By utilizing authentic, multi-source real-world data rather than modeled proxies, HealthVerity allows pharmaceutical brands and healthcare agencies to deploy highly accurate, clinically validated consumer cohorts across their entire media stack.
Most legacy syndicated segments rely heavily on open claims data alone or modeled proxies that fill information gaps with statistical assumptions. HealthVerity takes a different approach by anchoring its segments in real clinical signals across a massive ecosystem of 300M+ de-identified patients, 200B+ transactions, commercial Rx, specialty pharmacy and lab data. This allows marketers to distinguish actual diagnosed patients from "likely" ones, optimizing pharma DTC marketing precision from the start.
Yes. HealthVerity excels at disease targeting in any therapeutic area including highly specialized rare disease patient segments. The audiences are built on a foundational medical claims database spanning hundreds of billions of transactions and provides unparalleled cohort accuracy. Third-party media analytics show HealthVerity delivering up to 3x greater reach and accuracy for rare disease brands compared to traditional competitors.